Loading candles…
Bajaj Healthcare Ltd, incorporated in 1993 and headquartered in Thane, Maharashtra, operates in the pharmaceutical industry. The company manufactures a diverse range of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage formulations. It emphasizes backward integration to enhance cost-efficiency and ensure supply chain reliability. Bajaj Healthcare holds a leading global position in the production of Chlorhexidine base and maintains a dominant domestic presence in Ascorbic Acid (Vitamin C).
This page is a live market overview for BAJAJ HEALTHCARE LIMITED (BAJAJHCARE) on the NSE. As a listed security, BAJAJ HEALTHCARE LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BAJAJHCARE before placing trades on tick2trade.
As of the latest feed, BAJAJHCARE last traded at ₹329.8 on NSE, up ₹0.6 (0.18%) from the previous close of ₹329.2. Today's session range is ₹325.55 – ₹332.95, against a 52-week band of ₹272.35 – ₹515.9. Traded volume today stands at 90.95K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for BAJAJHCARE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BAJAJHCARE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BAJAJ HEALTHCARE LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BAJAJHCARE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BAJAJHCARE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 20 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 8 May 2026 |
| Fund Raising | To consider and approve the allotment of Equity Shares to the Promoter, Promoter Group and Person(s) belonging to the Non-Promoter Public Category, upon the … | 18 Mar 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 16 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 28 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.